-
WST-8 Glucose Uptake Assay for CPP Delivery
2026-09-12
Use a non-radioactive 450 nm readout to determine whether ion-assisted CPP–nucleic acid delivery produces a meaningful metabolic response, not merely particle internalization. This workflow combines formulation controls, glucose uptake phenotyping, and troubleshooting for cancer metabolism research, diabetes models, and broader cell-based studies.
-
WZ4003 Workflows for NUAK1/2 Inhibition
2026-09-11
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase engagement with changes in migration, proliferation, invasion, and tau phosphorylation. This practical guide shows how to build orthogonal assays, interpret brain-slice responses, and troubleshoot formulation or selectivity problems.
-
Isochlorogenic Acid A Hydrogel for Wound Repair
2026-09-11
A 2026 study developed an amylopectin/carboxymethyl chitosan hydrogel containing Isochlorogenic acid A/Fe(III) co-assembled nanoparticles to address the compound’s poor water solubility and stability. The composite dressing combined antibacterial activity, favorable mechanical and swelling properties, enhanced cell migration, and improved wound-healing-associated inflammatory and vascular markers in preclinical assays.
-
ApexPrep DNA Plasmid Miniprep Kit Guide
2026-09-10
Learn how ApexPrep DNA Plasmid Miniprep Kit (SKU A5001) can reduce plasmid-related variability in cloning, sequencing, transformation, transfection, and cell-based viability workflows. The article connects alkaline lysis plasmid purification with practical AML research design while distinguishing product-supported claims from laboratory recommendations.
-
AMG 9810: TRPV1 Antagonist Research Guide
2026-09-10
AMG 9810 is a selective competitive TRPV1 antagonist for dissecting capsaicin, proton, heat, and endogenous-ligand responses. Its nanomolar activity, reported inhibition of calcium influx and CGRP release, and defined solvent guidance support controlled sensory neuron signaling studies and pain mechanism research.
-
Methicillin sodium salt in Reliable Assays
2026-09-09
Learn how Methicillin sodium salt, SKU C3238, can improve interpretation of bacterial challenge, cell viability, proliferation, and cytotoxicity workflows. This scenario-driven guide covers mechanism, MSSA/MRSA controls, concentration selection, stock preparation, assay compatibility, and practical vendor evaluation.
-
Tofacitinib (CP-690550) in RA Macrophages
2026-09-09
Tofacitinib (CP-690550) is an oral JAK pathway inhibitor used to study cytokine signaling, lymphocyte activation, and inflammatory macrophage states. In a 2026 rheumatoid arthritis study, it reduced GM-CSFRα and STAT5-associated inflammatory and mitochondrial abnormalities in GM-CSF-reprogrammed macrophages.
-
Docosahexaenoic Acid: Applied Research Workflows
2026-09-08
Build reproducible DHA experiments around controlled lipid dosing, orthogonal stress readouts, and careful handling of oxidation-prone solutions. This workflow connects neuroprotection research with comparative immune-lipid assays while clearly separating evidence for DHA from findings reported for arachidonic acid.
-
IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis
2026-09-08
A 2025 study identifies an m6A-dependent IGF2BP1–THBS1–TLR4 pathway that links macrophage glycolytic reprogramming with fibrotic polarization in pulmonary fibrosis. Its knockdown, rescue, and metabolic experiments provide a mechanistic framework for interpreting how RNA stability and macrophage state contribute to bleomycin-induced lung injury.
-
Brain-to-Spinal Control of Opioid Pain Hypersensitivity
2026-09-07
Yin et al. identify a lateral parabrachial–hypothalamic–spinal circuit that regulates morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical opioid effects from better-established thermal mechanisms and provides a circuit framework for investigating opioid-related pain amplification.
-
Recombinant Mouse M-CSF: Assay Design Guide
2026-09-05
Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) is more than a macrophage expansion reagent. This guide explains how to use PM2021 to separate lineage support from macrophage activation, interpret fibrosis-related findings, and design more defensible assays.
-
SCH772984 HCl: Practical ERK1/2 Workflows
2026-09-05
Build sharper MAPK experiments with SCH772984 HCl, from acute ERK1/2 phosphorylation assays to BRAF- and RAS-driven proliferation studies. A carefully controlled extension into APEX2 and TERT research helps distinguish established pathway effects from testable new hypotheses.
-
Gepotidacin: From Target Engagement to Phenotype
2026-09-04
Gepotidacin, also known as GSK2140944, offers a powerful model for connecting bacterial topoisomerase inhibition with whole-cell antibacterial activity. This article presents an evidence-chain workflow that integrates biochemical, DNA-damage, phenotypic, and exposure-aware assays for more rigorous antibiotic resistance research.
-
BRD4–AKT–SIRT3 Signaling in Hyperoxic Lung Injury
2026-09-04
Qin et al. identify BRD4 as a mediator of hyperoxia-induced lung injury and connect its inhibition to activation of the AKT–SIRT3 pathway in alveolar type II epithelial cells. The study combines BRD4 knockdown with pathway-inhibition experiments to support a causal signaling hierarchy that links a chromatin regulator to oxidative-stress and apoptosis control.
-
Rotigotine in Experimental Depression Models
2026-09-03
The reference study tested rotigotine across several rat models and found behavioral effects consistent with antidepressant activity, particularly at doses at or below 1 mg/kg. Its central methodological contribution was separating mood-related behavioral improvement from high-dose locomotor stimulation, an essential consideration for interpreting dopamine agonists in Parkinson’s disease research.